Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients

British Journal of Cancer

Volumn 104, Issue 6, 2011, Pages 1000-1006

  Wong, S C C ^a   Ng, S S M ^a   Cheung, M T ^b   Luk, L Y ^b   Chan, C M L ^a   Cheung, A H K ^a   Lee, V H M ^b   Lai, P B S ^a   Ma, B B Y ^a   Hui, E P ^a   Lam, M Y Y ^a   Au, T C C ^a   Chan, A T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

CDX2 positive circulating tumour cells; clinical significance; colorectal cancer

Indexed keywords

TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL DISEASE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TUMOR EMBOLISM;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; SURVIVAL ANALYSIS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79952699244     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.32     Document Type: Article

References (38)

1. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904 (Pubitemid 39383039)
2. Bertario L, Russo A, Sala P, Pizzetti P, Ballardini G, Andreola S, Spinelli P (2003) Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer 105: 82-87 (Pubitemid 36418489)
3. Braun S, Naume B (2005) Circulating and disseminated tumor cells. J Clin Oncol 23: 1623-1626 (Pubitemid 46211415)
4. Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40: 403-439 (Pubitemid 34535443)
5. Church JM (2004) Clinical significance of small colorectal polyps. Dis Colon Rectum 47: 481-485 (Pubitemid 38436654)
6. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791 (Pubitemid 39095313)
7. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23: 1420-1430
8. Cristofanilli M, Mendelsohn J (2006) Circulating tumor cells in breast cancer: advanced tools for "tailored" therapy? Proc Natl Acad Sci USA 103: 17073-17074 (Pubitemid 44788923)
9. Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47: 624-630 (Pubitemid 32275803)
10. Filiz AI, Sucullu I, Kurt Y, Karakas DO, Gulec B, Akin ML (2009) Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients-is it important? Clinics (Sao Paulo) 64: 287-294
11. Gao X, Nie S (2003) Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol 21: 371-373 (Pubitemid 37025770)
12. Giribaldi G, Procida S, Ulliers D, Mannu F, Volpatto R, Mandili G, Fanchini L, Bertetto O, Fronda G, Simula L, Rimini E, Cherchi G, Bonello L, Maule MM, Turrini F (2006) Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method. J Mol Diagn 8: 105-112 (Pubitemid 43257441)
13. Glinskii AB, Smith BA, Jiang P, Li XM, Yang M, Hoffman RM, Glinsky GV (2003) Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models. Cancer Res 63: 4239-4243 (Pubitemid 36917952)
14. Herawi M, De Marzo AM, Kristiansen G, Epstein JI (2007) Expression of CDX2 in benign tissue and adenocarcinoma of the prostate. Hum Pathol 38: 72-78 (Pubitemid 44880202)
15. Jin Y, Sun A, Noriki S, Imamura Y, Fukuda M (2007) Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers. Eur J Histochem 51: 1-10 (Pubitemid 351480300)
16. Katsumata K, Sumi T, Mori Y, Hisada M, Tsuchida A, Aoki T (2006) Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR. Int J Clin Oncol 11: 385-389 (Pubitemid 44627660)
17. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H (1990) Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothe-lial. J Clin Pathol 43: 213-219 (Pubitemid 20087572)
18. Leite KR, Mitteldorf CA, Srougi M, Dall'oglio MF, Antunes AA, Pontes Jr J, Camara-Lopes LH (2008) Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer. Ann Diagn Pathol 12: 260-266
19. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast Jr RC (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: 5313-5327 (Pubitemid 46631379)
20. Mocellin S, Keilholz U, Rossi CR, Nitti D (2006) Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 12: 130-139
21. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C (1993) An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943-947 (Pubitemid 23244732)
22. Molnar B, Ladanyi A, Tanko L, Sréter L, Tulassay Z (2001) Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 7: 4080-4085 (Pubitemid 34044631)
23. Naoe M, Ogawa Y, Morita J, Omori K, Takeshita K, Shichijyo T, Okumura T, Igarashi A, Yanaihara A, Iwamoto S, Fukagai T, Miyazaki A, Yoshida H (2007) Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 109: 1439-1445 (Pubitemid 46466573)
24. Paterlini-Brechot P, Benali NL (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253: 180-204 (Pubitemid 47017533)
25. Payne JE (1989) International colorectal carcinoma staging and grading. Dis Colon Rectum 32: 282-285 (Pubitemid 19104318)
26. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K (2007) Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 13: 920-928 (Pubitemid 46340368)
27. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, Rafael S, Garcia-Saenz JA, Vidaurreta M, Martin M, Arroyo M, Sanz-Casla MT, Diaz-Rubio E (2008) Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 19: 935-938 (Pubitemid 351627310)
28. Sleijfer S, Gratama JW, Sieuwerts AM, Kraan J, Martens JW, Foekens JA (2007) Circulating tumour cells detection on its way to routine diagnostic implementation? Eur J Cancer 43: 2645-2650 (Pubitemid 350151847)
29. Smith AM, Dave S, Nie S, True L, Gao X (2006) Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn 6: 231-244 (Pubitemid 44167151)
30. Takakura Y, Hinoi T, Oue N, Sasada T, Kawaguchi Y, Okajima M, Akyol A, Fearon ER, Yasui W, Ohdan H (2010) CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium. Cancer Res 70: 6767-6778
31. Tan E, Gouvas N, Nicholls RJ, Ziprin P, Xynos E, Tekkis PP (2009) Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 18: 15-24
32. Valera V, Yokoyama N, Walter B, Okamoto H, Suda T, Hatakeyama K (2005) Clinical significance of Ki-67 proliferation index in disease progression and prognosis of patients with resected colorectal carcinoma. Br J Surg 92: 1002-1007 (Pubitemid 41160791)
33. Wang JY, Lin SR, Wu DC, Lu CY, Yu FJ, Hsieh JS, Cheng TL, Koay LB, Uen YH (2007) Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels. Clin Cancer Res 13: 2406-2413
34. Witek ME, Nielsen K, Walters R, Hyslop T, Palazzo J, Schulz S, Waldman SA (2005) The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Clin Cancer Res 11: 8549-8556 (Pubitemid 43005899)
35. Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT (2009) Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res 15: 1005-1012
36. Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL (2004) Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 10: 1401-1408 (Pubitemid 38365235)
37. Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Hsiao WL (2002) Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 196: 145-153 (Pubitemid 34110895)
38. Yamashita K, Watanabe M (2009) Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci 100: 195-199